Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $10.19
Used from: $1.62

The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
by Dr. Aaron Katz
Our Price: $10.19
Used from: $9.16

Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
by Gerald Chodak
Our Price: $11.37
Used from: $9.48

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $12.14

Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects
Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects
by Arthur L. Burnett II Norman Morris
Our Price: $11.53
Used from: $0.01



Prostate Cancer Drug Links


<< 1 2 3 >>




Prostate Cancer Drug Headlines


Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis - MarketWatch (press release)


Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis
MarketWatch (press release)
6, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the ...
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to ...Sacramento Bee

all 14 news articles »

Read more...


Medivation prostate cancer drug well-tolerated in trial - Fox News


MD News

Medivation prostate cancer drug well-tolerated in trial
Fox News
The drug is also being tested in patients with earlier-stage prostate cancer. The safety profile of the drug "looked good with no major red flags," said ISI Group analyst Mark Schoenebaum, adding that the seizure rate "could pose some concern as the ...
Medivation Surges on Prostate Cancer Drug: San Francisco MoverBusinessWeek
Medivation rises on prostate cancer drug dataCBS News
Medivation's Prostate Cancer Drug: Survival Benefit With Low Seizure RiskTheStreet.com
WebMD
all 90 news articles »

Read more...